Skip to main content
logo
KALA BIO, Inc. (KALA)
NASDAQ: KALA · Real-Time Price · USD
0.7297
+0.0563 (8.36%)
At close: Jul 30, 2026, 4:00 PM EDT
0.7100
-0.0197 (-2.70%)
After-hours: Jul 30, 2026, 7:56 PM EDT

KALA BIO Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
----3.8911.24
Revenue Growth
-----65.37%76.67%
Gross Profit
----1.337.14
Operating Income
-30.29-39.16-40.98-39.66-81.71-130.25
Net Income
-19.65-26.98-38.51-42.2-44.82-142.61
Earnings Per Share
-96.14-165.50-507.50-867.50-1474.00-5416.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
8.767.5651.1850.970.592.14
Total Debt
0032.2536.3242.9580.19
Net Cash (Debt)
8.767.5618.9314.5727.5511.95
Net Cash Growth
-11.23%-60.08%29.90%-47.10%130.54%-77.30%
Net Cash Per Share
2.8346.37249.33299.59905.72453.78

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-26.06-31.99-29.38-27.93-78.91-108.24
Capital Expenditures
--0.02-0.21-0.61-0.31-0.89
Free Cash Flow
-26.06-32.01-29.59-28.54-79.22-109.12
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----34.22%63.55%
Operating Margin
-----2099.33%-1158.76%
Pretax Margin
-----1151.64%-1268.73%
Profit Margin
-----1151.64%-1268.73%
FCF Margin
-----2035.48%-970.83%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-0.610.610.610.61-
PS Ratio
----16.737.12